Cargando…
COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111551/ https://www.ncbi.nlm.nih.gov/pubmed/35384115 http://dx.doi.org/10.1111/cea.14143 |
| _version_ | 1784709284451319808 |
|---|---|
| author | Csuth, Àgnes Nopp, Anna Storsaeter, Jann Nilsson, Lennart Jenmalm, Maria C. |
| author_facet | Csuth, Àgnes Nopp, Anna Storsaeter, Jann Nilsson, Lennart Jenmalm, Maria C. |
| author_sort | Csuth, Àgnes |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9111551 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91115512022-05-17 COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E Csuth, Àgnes Nopp, Anna Storsaeter, Jann Nilsson, Lennart Jenmalm, Maria C. Clin Exp Allergy Research Letters John Wiley and Sons Inc. 2022-04-28 2022-06 /pmc/articles/PMC9111551/ /pubmed/35384115 http://dx.doi.org/10.1111/cea.14143 Text en © 2022 The Authors. Clinical & Experimental Allergy published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Research Letters Csuth, Àgnes Nopp, Anna Storsaeter, Jann Nilsson, Lennart Jenmalm, Maria C. COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title | COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title_full | COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title_fullStr | COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title_full_unstemmed | COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title_short | COVID‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and Immunoglobulin E |
| title_sort | covid‐19 vaccines and anaphylaxis—evaluation with skin prick testing, basophil activation test and immunoglobulin e |
| topic | Research Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9111551/ https://www.ncbi.nlm.nih.gov/pubmed/35384115 http://dx.doi.org/10.1111/cea.14143 |
| work_keys_str_mv | AT csuthagnes covid19vaccinesandanaphylaxisevaluationwithskinpricktestingbasophilactivationtestandimmunoglobuline AT noppanna covid19vaccinesandanaphylaxisevaluationwithskinpricktestingbasophilactivationtestandimmunoglobuline AT storsaeterjann covid19vaccinesandanaphylaxisevaluationwithskinpricktestingbasophilactivationtestandimmunoglobuline AT nilssonlennart covid19vaccinesandanaphylaxisevaluationwithskinpricktestingbasophilactivationtestandimmunoglobuline AT jenmalmmariac covid19vaccinesandanaphylaxisevaluationwithskinpricktestingbasophilactivationtestandimmunoglobuline |